The links below offer some coverage of
Dr. Clark’s speaking engagements
Guide for Future Directions for the Addiction and OUD Treatment Ecosystem
Money appropriated from Congress has not been spent. The addiction treatment system is inadequate in quantity and quality to address the need for care. To build an appropriate addiction treatment system requires addressing “The 4 C’s” : Capacity, Competency, Consistency, and Compensation. Read this product of the Prevention, Treatment, and Recovery Workgroup of the National Academy of Medicine’s Action Collaborative to Counter the US Opioid Crisis by R. Corey Waller and Kelly J Clark et al.
Opioid Addiction: A Crisis Fueled by Stigma
Milken Institute, Washington, DC
October 29, 2019
General Addiction Health
Kentucky Health. Treating Drug Addiction, October 2017
Interview of Dr. Clark by Dr. Wayne Tuckson
In PBS NewsHour coverage on Dr. Clark’s appearance at White House meeting in June 2017, she was quoted as telling the commission that to lower deaths resulting from opioid use disorder, decision makers must support evidence-based treatment, evidence-based prevention and workforce development to get help where it’s needed.
She is quoted in this link commenting on the lack of efficiency in Medicaid spending for care that is evidence based.
State Medicaid Rules can Be a Hurdle in the Battle with Addiction
Dr. Clark has spoken frequently on how state Medicaid rules often hurt in the battle against addition. See two media citations in October 2016 in the following links:
Congress and the Opioid Epidemic
In the following link you can read Dr. Clark’s assessment for working with the 115th Congress on the opioid epidemic.
Dr. Clark is interviewed by Fox News Health on how to help someone who is addicted to drugs.
Medication Assisted Treatment (MAT)
Dr. Clark is cited in this Washington Post article on the importance of Medication Assisted Treatment (MAT)
Physician Limitations on Prescribing Buprenorphine Can Create Roadblocks to Care
Currently there are limitations on the number of patients for which a physician or advanced practitioner can prescribe buprenorphine when it is being used as a Medication Assisted Treatment (MAT) in addiction. These limitations are restricting access to care and Dr. Clark has been working hard for years to have these limitations increased to more appropriate levels. Below are several examples of her efforts to speak out on this issue.
The American Journal of Managed Care is the leading peer reviewed journal in managed care. Dr. Clark comments in video and written format on how restriction on physician prescriptions for buprenorphine can create several patient access roadblocks when needed for opioid addiction.
This link takes you to a Q&A on the subject of the buprenorphine prescribing limits.
This link takes you to an interview with CHNI on the same topic.
More discussion on the cap on buprenorphine prescribing in the legislative process in the following links: